Antiplatelet therapy: current strategies and future trends

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Hematology

Background:

• Antiplatelet therapy is crucial for managing thrombotic complications.
• Current strategies show limitations in preventing recurrent thrombotic events in certain patients.
• Evolving clinical guidelines and emerging drug classes necessitate a review of treatment approaches.

Purpose of the Study:

• To review current antiplatelet treatment strategies for thrombotic complications.
• To highlight emerging pharmacological agents and future therapeutic directions.
• To emphasize the potential of personalized medicine in thrombosis management.

Main Methods:

• Review of recent clinical trials and guideline modifications.
• Analysis of ongoing research into novel antiplatelet and antithrombotic agents.
• Exploration of future therapeutic strategies, including personalized approaches.

Main Results:

• Current antiplatelet strategies require improvement to effectively inhibit recurrent thrombotic events.
• New P2Y(12) receptor inhibitors and thrombin inhibitors are in late-stage clinical trials.
• Novel agents targeting coagulation, platelet adhesion, and specific receptors show promise.

Conclusions:

• Advancements in antiplatelet and antithrombotic therapies are ongoing.
• Personalized therapy, based on individual thrombosis propensity, represents a significant future direction.
• Integrating patient-specific pathophysiology into treatment selection will enhance therapeutic efficacy.